Background: Patients with dementia may be unable to describe their symptoms, and caregivers frequently suffer emotional burden that can interfere with judgment of the patient's behavior. The Neuropsychiatric Inventory-Clinician rating scale (NPI-C) was therefore developed as a comprehensive and versatile instrument to assess and accurately measure neuropsychiatric symptoms (NPS) in dementia, thereby using information from caregiver and patient interviews, and any other relevant available data. The present study is a follow-up to the original, cross-national NPI-C validation, evaluating the reliability and concurrent validity of the NPI-C in quantifying psychopathological symptoms in dementia in a large Brazilian cohort.
Introduction
In addition to cognitive and functional impairment, neuropsychiatric symptoms (NPS) are a near universal aspect of a dementia diagnosis (Gauthier et al., 2010; Dubois et al., 2010; Lyketsos et al., 2011) . NPS contribute to increases in the patient's clinical deterioration and caregiver burden, and lead to diminished quality of life for patients and family members. NPS also predict likelihood of earlier institutionalization, interact with other comorbidities, accelerate disease progression, and increase mortality risk (Gauthier et al., 2010; Lyketsos et al., 2011; Lyketsos and Miller, 2012; Wadsworth et al., 2012) . In addition, multiple co-occurring NPS (e.g., depression with apathy, irritability with aggression, or delusions with agitation) complicate the clinical picture, creating challenges for diagnosis and treatment (Brodaty et al., 2001; Lopez et al., 2003; de Medeiros et al., 2010; Lyketsos et al., 2011; Benoit et al., 2012) . In Brazil, several cohort studies found high prevalences of NPS in dementia, namely apathy, agitation, aggression, depression, sleep disturbances, anxiety, and aberrant motor behavior (Tatsch et al., 2006; Camozzato et al., 2008; Truzzi et al., 2013) .
Even in prodromal stages of dementia, NPS may also be present; indeed, recent studies have shown that the occurrence of NPS in patients with mild cognitive impairment (MCI) may increase the risk of subsequent progression to dementia (Taragano et al., 2009; Di Iulio et al., 2010; Lyketsos et al., 2011) . Sperling and colleagues (2011) postulated that cognitive and behavioral changes could represent an early stage of a progressive dementia in individuals with evidence of a long asymptomatic period characterized by neuropathological Alzheimer's disease (AD) biomarkers. Accurate measurement of NPS, even at early stages of dementia, is therefore critical for diagnosis and treatment (Gauthier et al., 2010; Lyketsos et al., 2011; Sperling et al., 2011) .
Despite approaches to improve accurate measurement of NPS in dementia, there are several major challenges for clinicians and researchers. Many existing measurements are based solely on patient's or caregiver's inputs, leading to significant measurement limitations. The patient may be unable to provide reliable information due to cognitive decline (e.g., forgetfulness) or lack insight; caregivers frequently suffer emotional burden that interferes with appropriate judgment of the patient's behavior (Rosenberg et al., 2005; de Medeiros et al., 2010; Lyketsos et al., 2011) . Reports by patients and caregivers alone may, therefore, not provide a complete or accurate picture of NPS. In contrast, clinicians with training in NPS screening in patients with dementia should be able to incorporate caregiver and patient information along with their clinical judgment to achieve a better understanding of the behavioral syndrome. This strategy of using clinical impression ratings can improve accuracy in measuring the clinical relevance of each symptom, as well as in distinguishing neuropsychiatric conditions when symptoms overlap, for instance deciding whether a given symptom is due to apathy or depression, a decision usually difficult for the non-clinician (de Medeiros et al., 2010; Benoit et al., 2012) .
The Neuropsychiatric Inventory-Clinician rating scale (NPI-C) is a comprehensive and versatile psychometric scale that has been designed to measure NPS both in clinical and research settings. As compared to similar instruments designed for the same purpose, the NPI-C rating incorporates the expert clinician's impressions (i.e., all relevant information according to his/her clinical judgment and patient records) to the data provided by patients and caregivers. The NPI-C output may be readily compared across distinct investigation sites, which renders it particularly useful for clinical trials (de Medeiros et al., 2010; Lyketsos et al., 2011) .
The present study is a follow-up to the original, cross-national NPI-C validation (de Medeiros et al., 2010) , evaluating the reliability and concurrent validity of the NPI-C in quantifying psychopathological symptoms in dementia in a large Brazilian cohort.
Although Brazil was one of the nine international sites that participated in original NPI-C validation study, the present Brazilian cohort study is justified for several reasons. First, sociocultural context may influence caregivers' beliefs, perceptions, and attitudes with regional variations in Latin America (Peluso and Blay, 2004) . This was not possible to consider in the international validation study in which 15 patient/caregiver dyads participated. Also, the lack of socioeconomic resources associated with recent political decisions has led to shortages in long-stay nursing homes for people with dementia (Creutzberg et al., 2007) , requiring families to provide care at home, often with increasing emotional burden. Low levels of education still are also common in Brazil, and have become an additional problem for the poorest people. Taken together, these factors contribute to caregiver difficulties in interpreting NPS and point to the importance of a large NPI-C validation study in Brazil.
Another important rationale for the current study is apathy assessment. The original validation of the NPI-C used the Apathy Evaluation Scale (AES; Marin et al., 1991) for convergent validity. However, as noted in the original article, data on the AES for the Brazilian subgroup were excluded from analyses due to rater discrepancies in the interpretation of some AES items (de Medeiros et al., 2010 ). In the current study, the Apathy Inventory (AI; Robert et al., 2002; , an instrument already validated for Brazilians community (Stella et al., 2013) , was used instead of the AES.
Methods
Structure of the NPI-C The development and cross-national validation of the NPI-C was led by de Medeiros and Lyketsos with the participation of an international group including researchers from Argentina, Australia, Brazil, Canada, France, Greece, Hungary, Italy, and the USA. This group worked closely with the original developer of the Neuropsychiatric Inventory (NPI; Cummings, 1994 ). De Medeiros et al. (2010 published the final version of the NPI-C, making it available for researchers and clinicians.
The NPI-C encompasses all traditional NPI domains (agitation and aggression are split into individual domains in the NPI-C), includes more items and one new domain (aberrant vocalizations), and uses clinician judgment to rate the severity of each neuropsychiatric symptom (de Medeiros et al., 2010) . These improvements rectified important weaknesses of the traditional NPI such as possible biases caused by emotional stress and excessive burden to family members or caregivers, and possible cognitive decline when the caregiver is older and may also suffer from memory loss, which could compromise the response reliability and accuracy. In each domain of the NPI-C, the clinician ultimately decides on the clinical value of each symptom considering responses from a knowledgeable informant, the direct interview with the patient, and additional relevant information from the patient's record or from direct observation of the patient's behaviors. This clinician judgment provides more accurate assessment of NPS in dementia. The NPI-C is available to be used as a broad-spectrum scale or as a single tool driven to selected neuropsychiatric domains.
The NPI-C was translated into Portuguese (Brazil) (Inventário Neuropsiquiátrico -Avaliação do Clínico -NPI-C): An independent expert in English performed the back-translation into English to verify the reliability of the text to be used in Brazil.
As mentioned earlier, one limitation of the traditional NPI concerns scoring that is based solely on caregiver reports provided during a clinical interview . Caregivers provide a global rating of frequency, severity, and caregiver distress for each of 12 NPS domains. Two relevant changes were incorporated in the NPI-C. First, rather than provide a global rating, caregivers are asked to rate individual symptoms within a domain for frequency, severity, and caregiver distress. Since it is well known that caregiver informants often suffer emotional burdens that may lead to biased reporting of the patient's symptomatology, the second important change is a clinical judgment rating of NPS. The clinician now provides a rating for each item in each domain based on an interview with the caregiver (and or other informants), direct observation of and interaction with the patient, and additional information from the patient record. The clinician scoring assessment minimizes potential inaccuracies or misinterpretation of symptoms (e.g., confusing apathy with depression) by the caregiver (de Medeiros et al., 2010; Lyketsos et al., 2011) . Thus, changes in the NPI-C represent a rating approach that can reduce inappropriate influences from caregivers or family members when they report the nature or severity of NPS.
Inclusion criteria
In the present study, the inclusion criteria were the same applied to the original validation of the NPI-C (de Medeiros et al., 2010) , and were divided into two parts: (a) knowledgeable informants and (b) patients. For knowledgeable informants (caregiver or family members), inclusion criteria were capacity to identify and to report on NPS in the patient over the past month, and having maintained regular verbal contact with the patient at least three times a week during the past three months. Patients were included if they had a medical diagnosis of probable AD as well as a knowledgeable informant (caregiver or family member).
Sample
We studied 312 participants from five Brazilian centers (156 patient-knowledgeable informant dyads), who completed the NPI-C with two blinded raters, totaling 624 observations. In these centers (São Paulo, Rio de Janeiro, Campinas, São José do Rio Preto, and Rio Claro), the raters determined dementia severity by the Mini-Mental State Examination (MMSE; Folstein et al. 1975) , the Clinical Dementia Rating (CDR; Hughes et al., 1982) , the Pfeffer Functional Activities Questionnaire (Pfeffer, 1982) , and the Global Deterioration Scale (GDS; Reisberg et al., 1982) . Table 1 summarizes participant demographic and clinical data including the MMSE, CDR, and GDS.
Ethics review boards approved the study, and family members or legal representatives signed written informed consent, as did as patients who were able to understand the purpose of investigation. The research was conducted according to the principals of the Helsinki Declaration.
Procedures
We performed a cross-sectional investigation of patients and respective caregivers to estimate interrater reliability and convergent validity of the Brazilian translation of the NPI-C. For the validation of the NPI-C, all participants (100%) completed the scale.
I N T E R -R A T E R R E L I A B I L I T Y
At each center, two independent and trained raters interviewed each knowledgeable informant/patient dyad at different times (in general, in the same day or at least within the same week) in order to estimate the inter-rater reliability of the NPI-C. Before administering the measure, an investigator (Florindo Stella) who previously had participated in the original validation of the NPI-C trained the raters on completion of all study scales. Eligible clinician raters for this study were working regularly at specialized centers with patients with dementia observing or making diagnostic procedures, providing appropriate care, counseling caregivers or family members, and establishing or following pharmacological or non-pharmacological treatment. Each independent rater completed the NPI-C. At first, caregivers were asked to rate the frequency and severity of each item in each domain, as well as estimate their distress level due to the patient's behavior. In addition, raters interviewed the patient. This provided them an opportunity to interact with the patient and, when possible, to obtain the patient's insight into their recent experiences that may be related to NPS. Based on caregiver answers, patient interview, and any additional clinical information (e.g., a specific report from the patient record), raters used their experience and judgment to determine the final score for each symptom of the NPI-C. Symptom scores in each of the 14 domains were added up to produce total clinician rating domain scores. Inter-rater reliability was determined through calculation of intraclass correlation coefficients for the NPI-C domain scores, as well as for those of the traditional NPI that was administered as part of the NPI-C (Shrout and Fleiss, 1979) .
In addition to estimating the convergent validity of specific domains of the NPI-C and to make appropriate correlations, one of the two raters completed four selected scales: the Brief Psychiatric Rating Scale (BPRS; Ventura et al., 1993) ; the Cohen-Mansfield Agitation Index (CMAI; CohenMansfield et al., 1989) ; the Cornell Scale for Depression in Dementia (CSDD; Alexopoulos et al., 1988) ; and the AI (Robert et al., 2002; . In order to obtain precise information about NPS, the scales were completed regardless of the caregiver's response to the screening question for each of the NPI-C domains.
Pearson correlations of these data were used to provide statistical support for convergent validity, as well as for test-retest reliability.
Within the convergent validity strategy, we expected moderate to strong association of NPI-C domains with selected scales, with significant correlations between correspondent assessments. Furthermore, at the end of the interview, each rater estimated the assessment of respondent's reliability using a short questionnaire based on distinct questions requiring sequential levels (0 = poor; 1 = fair; 2 = good; 3 = excellent). Considering the quality of information provided during the interview, each rater scored the response reliability from the same caregiver.
Data analyses
Descriptive analyses including mean, standard deviation, and frequency were estimated for general demographic data such as age, gender, and years of education, as well as clinical performance on scores from performance on the MMSE, Pfeffer Functional Activities Questionnaire, CDR, GDS, CMAI, BPRS, CSDD, and AI. Inter-rater reliabilities for each NPI-C and NPI domain were estimated by calculating intraclass correlations (ICC).
Convergent validity was estimated by calculating Pearson correlations coefficient between NPI-C domains and selected scales (NPI-C/delusions vs. BPRS; NPI-C/hallucinations vs. BPRS; NPI-C/agitation vs. CMAI; NPI-C/aggression vs. CMAI; NPI-C/aberrant vocalizations vs. CMAI; NPI-C/depression vs. CSDD; and NPI-C/apathy vs. AI). We also examined convergent validity by dementia severity based on CDR scores. A one-way ANOVA was applied to identify differences between scores from clinical data, relative to CDR severity levels. All statistical analyses were carried out using SPSS 20.0. Table 1 displays demographic and clinical data from patients (n = 156) according to severity levels of dementia based on CDR scores: 60 had mild dementia (CDR 1), 53 moderate (CDR 2), and 43 severe (CDR 3). As expected, the scores of the MMSE were progressively worse according to clinical deterioration in the CDR severity levels (one-way ANOVA, p < 0.01). Likewise, the Pfeffer Questionnaire showed greater impairment of daily living activities among patients with more severe CDR (one-way ANOVA; p < 0.05). These data are compatible with the global impairment measured by the GDS relative to the CDR (one-way ANOVA, p < 0.05). In turn, psychopathological symptoms assessed by the AI, BPRS, and CMAI were progressively severe according to the CDR (one-way ANOVA, p < 0.01). Conversely, depressive symptoms, assessed by the CSDD, remained without significant changes in the three groups of the CDR (one-way ANOVA, p = 0.09). Results from these analyses are displayed in Table 1 .
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Results

Demographic and clinical features
Inter-rater reliability
Inter-rater reliability was strong (ICCs with 95% confidence limits) for all NPI-C domains. In addition, inter-rater reliability was strong for the NPI traditional score (r = 0.923). Data are included in Table 2 . Table 3 reports Pearson correlations coefficients with their 95% confidence intervals for convergent validity. There were significant correlations of specific NPI-C domains with selected scales.
Convergent validity
Based on dementia severity according to CDR levels, Table 4 includes correlations between specific NPI-C domains and selected scales that measure the same psychopathological syndromes with 95% confidence intervals for concurrent validity.
Hallucinations had the lowest correlation within the validity analysis. The correlations were not significant for hallucinations or aberrant vocalizations at any CDR level.
Concerning the respondents' assessment of reliability, 109 caregivers completed the short questionnaire with each rater at ending of the interview. According to Pearson correlations, the caregiver reliability was moderate (r = 0.601; 95% CI = 0.47, 0.71).
Discussion
The present study aimed to estimate the convergent validity and inter-rater reliability of the Brazilian version of the NPI-C. In doing so, the study covers an important gap in the measurement of psychopathological symptoms in dementia in Brazilians community.
As mentioned, although the Brazilian group participated in the original validation of the NPI-C, different sociocultural aspects support the current Brazilian cohort study. Regional features, mainly associated with low levels of education and distinct perceptions of behavioral disturbances in demented patients, as well as emotional exhaustion in familial caregivers are different than caregivers and patients from developed countries (Peluso and Blay, 2004; Creutzberg et al., 2007; Truzzi et al., 2013) .
Inter-rater reliability
Inter-rater reliability was strong for all NPI-C domains. In general, correlations from this study are consistent with data from the original NPI-C validation by de Medeiros et al. (2010) . The achieved correlation coefficients of the scores from independent raters can be considered reliable. Concerning total scores from the traditional NPI, in our study inter-rater reliability was higher than the moderate caregiver reliability. The discrepancy in reliability between raters and caregivers on interpretation of patients' symptoms reinforces the need for the clinician judgment such as the rating method used in the NPI-C regarding NPS in dementia. Table 3 . Pearson correlations and confidence intervals (95% confidence intervals) for concurrent (convergent) validity involving the NPI-C and selected scales (patients = 156) by the strength of correlation Table 4 . Pearson correlations (95% confidence intervals) for concurrent (convergent) validity involving the NPI-C and selected scales by the CDR (patient severity) rating 
Convergent validity
The convergent validity appears to be close to that of the original version of the NPI-C (de Medeiros et al., 2010) . There was a strong correlation between most NPI-C domains and the selected validation scales. The highest correlation was observed between the NPI-C/apathy domain and the AI, much stronger than data reported in the original validation study. In the original NPI-C validation, the NPI-C/apathy domain had weaker correlation with the AES (Marin et al., 1991) . We correlated this domain with the AI (Robert et al., 2002; , which is more suitable to the dementia setting, and convergent validity was strongest for this domain and corresponding measures. Nevertheless, while we observed the strongest correlation between the apathy domain and the AI (0.942), apathy had the weakest correlation in the original study when the AES instrument was used (0.31). Conversely, we found the lowest correlation for the hallucinations domain and the BPRS (0.432), while in the original study this correlation was higher (0.60). Therefore, the major discrepancies between both studies were related to the NPI-C/apathy and NPI-C/hallucinations domains. At least in part, the discrepancy regarding hallucinations domain could be related to conflicting responses by caregivers or their interpretation of patient's psychopathological manifestations. The occurrence of distinct types of hallucination-related behaviors, described by caregivers or observed in patients, may have influenced the understanding of symptoms and reporting them. These factors would affect the ICC value concerning the correlation between the NPI-C/hallucinations and the BPRS. Concerning apathy, as we mentioned earlier in the Methods section, the AES was problematic for the Brazilian site in the original NPI-C study. To address this issue in the current study, we replaced the AES by the AI (Robert et al., 2002; , which was already adapted and validated for Brazilians community with good specificity (97.3%) and sensitivity (99.2%) (Stella et al., 2013) .
We also examined concurrent validity by dementia severity. We note some differences in the strength of correlation by NPS. Specifically, there was exceptionally strong correlation between the NPI-C/apathy and the AI and NPI-C/depression and the CSDD in mild-to-moderate dementia. The strength of correlation declined in more severe patients. As observed in the Results section, the NPI-C/hallucinations domain had the lowest correlation with the BPRS. In addition, the correlations were not significant for NPI-C/hallucinations or NPI-C/aberrant vocalizations at any CDR level.
Perhaps the biggest surprise was the difference in correlation for NPI-C aberrant vocalizations and the CMAI for mild and moderate patients (r = 0.65 and 0.63, respectively) compared to the severe patients (r = 0.09). This is likely due to lack of communicative ability in late stages of dementia.
Patients with more clinical severity of AD showed higher scores on the CMAI (in which the domain NPI-C/aberrant vocalizations was inserted) in the original version and in the present study. In Brazil, we still need studies comparing the prevalence or intensity of NPS, including aberrant vocalizations, with severity levels of AD. In long-stay nursing homes, where there tends to be a high number of patients with advanced dementia, it would be possible to identify high prevalence and intensity of this clinical syndrome.
Psychopathological features
In agreement with the original study in the current convergent validity, most NPI-C domains had high correlations with selected scales (NPI-C/apathy vs. AI; NPI-C/agitation vs CMAI; NPI-C/aggression vs. CMAI; NPI-C/delusions vs. BRPS; NPI-C/depression vs. CSDD; and NPI-C/aberrant vocalizations vs. CMAI).
The question if depression and apathy integrate into the same syndrome or belong to the distinct psychopathological condition has been a continuous debatable matter (Aalten et al., 2007) . The NPI-C includes specific items, which appropriately discriminate one syndrome from another. While the core of apathy relates to reduced goal-directed behavior, reduced goal-directed cognition, and emotional blunting (Robert et al., 2010; Benoit et al., 2012) ; depression essentially concerns emotional disturbances by sadness and decreased pleasure in daily activities.
In estimating convergent validity for the NPI-C against the CMAI, the strength of correlation was high concerning the agitation (0.772) and aggression (0.769) domains. Whereas agitation may emerge in combination with different neuropsychiatric syndromes, this domain can be targeted as a stand-alone measure as was established in the original version of the NPI-C (de Medeiros et al., 2010) . Agitation includes uncommon physical or verbal non-threatening behavior, such as wandering, uncooperative attitudes, resistance to care, or unusual nonthreatening communication. Conversely, aggression comprises angry behavior, including physical or verbal threatening attitudes, intentional attempts to hit or hurt people or things, and uncommon threatening screams toward self or other person. Based on specific psychopathological features and different prevalence rates (Lyketsos et al., 1999; Brodaty et al., 2001) , the NPI-C considered agitation and aggression as two separate domains with insertion of new items to each (de Medeiros et al., 2010) .
Aberrant vocalizations was a new domain added to the NPI-C and also was compared with the CMAI since this scale comprises some items concerning verbal behavioral disturbances with moderate correlation (0.684). Aberrant vocalizations constitute a prominent framework in advanced dementia, and this domain was added to the NPI-C in order to capture symptoms present in this dementia stage (de Medeiros et al., 2010) .
The delusions domain from the NPI-C highly correlated with the BPRS (0.713). Hallucinations domain from the NPI-C presented only a moderate correlation with the BPRS (0.432).
The reliability of responses to each rater during the interview, available for 109 caregivers, was moderate (r = 0.601). This is an important point to be considered because it reveals some degree of change in the quality of information provided by the caregiver to each rater. During the interview, emotional reactions involving the caregiver and rater relationship, such as anxiety or difficulties in interpersonal relationship, and patient's irritability, could interfere with the quality of responses.
In general, the concurrent validity was supported by good coefficient correlations of NPI-C domains with selected scales measuring the same neuropsychiatric syndromes. Furthermore, the validity and reliability of the scale suggest it would be a useful tool for Brazilian communities to assess neuropsychiatric syndromes through both clinical practice and research.
Low quality of accuracy in assessing of psychopathological manifestations in dementia is an important problem for diagnosis and treatment. Appropriate methodological strategies are critical to assess NPS in patients with dementia through valid, sensitive, and reliable instruments. These resources provide crucial information to the clinician in order to adequately interpret the patient's psychopathological syndromes. In the NPI-C, the clinician rating approach minimizes the caregiver's misidentification concerning the patient's behaviors. It improves the accuracy in each NPI-C domain by direct observation of and interview with the patient, and by other relevant clinical information in addition to the caregiver's report. Likewise, improved diagnosis accuracy may facilitate appropriate potential treatment.
In Brazil, efforts are needed to achieve reliable and valid measures of cognition, function, and NPS in dementia (Tatsch et al., 2006; Memória et al., 2013; Truzzi et al., 2013) . The availability of the Brazilian-validated version of the NPI-C could represent a useful contribution for research and clinical trials on neuropsychiatric syndromes in dementia. The results demonstrate strong correlations of NPI-C domains with selected scales, which measure the same psychopathological syndromes. The high convergent validity and inter-rater reliabilities provide support for the use of the NPI-C across clinical and research settings, as well as in clinical trials.
Conclusion
The NPI-C is a comprehensive tool, which provides accurate measurement of NPS in dementia with high concurrent validity and inter-rater reliability in the Brazilian setting. In addition to universal assessment, the NPI-C can be completed by individual domains, such as delusions, hallucinations, agitation, depression, apathy, sleep disorders, etc. Additional efforts to use the NPI-C in Brazil targeting a comprehensive approach to psychopathological symptoms in dementia or to apply an individual NPI-C domain to investigate a distinct neuropsychiatric syndrome should be encouraged across clinical trials and research settings, as well as clinical practice.
